DoD Awards $9.7M Contract to SRI International for ARPA-H DigiHeals Project

Contract Overview

Contract Amount: $9,755,355 ($9.8M)

Contractor: SRI International

Awarding Agency: Department of Defense

Start Date: 2023-09-30

End Date: 2025-12-31

Contract Duration: 823 days

Daily Burn Rate: $11.9K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 1

Pricing Type: COST PLUS FIXED FEE

Sector: R&D

Official Description: SRI R&D PROJECT UNDER ARPA-H SHARE DIGIHEALS BAA

Place of Performance

Location: SAN DIEGO, SAN DIEGO County, CALIFORNIA, 92101

State: California Government Spending

Plain-Language Summary

Department of Defense obligated $9.8 million to SRI INTERNATIONAL for work described as: SRI R&D PROJECT UNDER ARPA-H SHARE DIGIHEALS BAA Key points: 1. SRI International secured a $9.7M contract for a biotechnology R&D project. 2. The contract falls under the ARPA-H initiative, focusing on digital health solutions. 3. Competition was full and open, suggesting a potentially competitive pricing environment. 4. The project is categorized under Biotechnology Research and Development. 5. The contract duration is over two years, ending in December 2025.

Value Assessment

Rating: fair

The contract value of $9.7M for a two-year R&D project appears reasonable given the specialized nature of ARPA-H initiatives. Benchmarking against similar advanced biotechnology R&D contracts would provide a clearer picture of value.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

The contract was awarded under full and open competition, indicating multiple vendors had the opportunity to bid. This method generally promotes competitive pricing and allows the government to select the best value offering.

Taxpayer Impact: The taxpayer impact is tied to the effective utilization of funds for advanced research with potential long-term health benefits, balanced against the initial investment.

Public Impact

Advancement in digital health technologies through ARPA-H funding. Potential for improved healthcare delivery and patient outcomes. Investment in cutting-edge biotechnology research and development. Support for innovation within the defense and healthcare sectors.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

  • Contract duration extends beyond typical R&D project timelines.
  • Specific deliverables and success metrics for the BAA are not detailed.
  • Potential for cost overruns in complex R&D projects.

Positive Signals

  • Awarded under ARPA-H, a high-impact innovation program.
  • Full and open competition suggests a robust selection process.
  • SRI International is a reputable research organization.

Sector Analysis

This contract falls within the Biotechnology R&D sector, a rapidly evolving field with significant government investment. Benchmarks for similar ARPA-H funded projects are difficult to establish due to their unique and cutting-edge nature.

Small Business Impact

The data indicates this contract was not awarded to a small business. There is no information provided on whether small businesses were subcontracted for this project.

Oversight & Accountability

The contract is managed by the Defense Logistics Agency, suggesting established oversight mechanisms. However, the specific oversight for ARPA-H projects and their unique research goals requires further examination.

Related Government Programs

  • Research and Development in Biotechnology (except Nanobiotechnology)
  • Department of Defense Contracting
  • Defense Logistics Agency Programs

Risk Flags

  • Contract duration is lengthy for an R&D project.
  • Lack of specific details on deliverables and success metrics.
  • Potential for scope creep in advanced research projects.
  • Cost-plus contracts can carry inherent cost overrun risks.

Tags

research-and-development-in-biotechnolog, department-of-defense, ca, definitive-contract, 1m-plus

Frequently Asked Questions

What is this federal contract paying for?

Department of Defense awarded $9.8 million to SRI INTERNATIONAL. SRI R&D PROJECT UNDER ARPA-H SHARE DIGIHEALS BAA

Who is the contractor on this award?

The obligated recipient is SRI INTERNATIONAL.

Which agency awarded this contract?

Awarding agency: Department of Defense (Defense Logistics Agency).

What is the total obligated amount?

The obligated amount is $9.8 million.

What is the period of performance?

Start: 2023-09-30. End: 2025-12-31.

What are the specific technological advancements expected from the DigiHeals project, and how do they align with ARPA-H's mission?

The DigiHeals project, funded by ARPA-H, likely aims to develop novel digital health solutions. These could range from AI-driven diagnostics and personalized treatment platforms to advanced remote patient monitoring systems. The alignment with ARPA-H's mission would be in fostering breakthrough technologies with the potential for transformative impact on health and national security.

What are the key performance indicators (KPIs) and milestones for this R&D contract, and how will SRI International's progress be measured?

Key performance indicators and milestones for R&D contracts, especially those under ARPA-H, are typically defined in the Broad Agency Announcement (BAA) and subsequent contract details. Progress is usually measured through regular technical progress reports, prototype demonstrations, peer reviews, and achievement of specific research objectives within defined timelines. The 'cost plus fixed fee' structure implies payment is based on incurred costs plus a negotiated fixed fee, contingent on meeting performance standards.

How does the 'full and open competition' process for this BAA ensure the most innovative and cost-effective solutions are selected for ARPA-H initiatives?

Full and open competition allows any interested and qualified source to submit a proposal, fostering a wide range of innovative approaches. This broad participation increases the likelihood of discovering novel solutions and encourages competitive pricing as multiple entities vie for the contract. For ARPA-H, this process is crucial for identifying breakthrough technologies that might not emerge through more restrictive procurement methods, ensuring taxpayer funds support the most promising advancements.

Industry Classification

NAICS: Professional, Scientific, and Technical ServicesScientific Research and Development ServicesResearch and Development in Biotechnology (except Nanobiotechnology)

Product/Service Code: RESEARCH AND DEVELOPMENTC – National Defense R&D Services

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Offers Received: 1

Pricing Type: COST PLUS FIXED FEE (U)

Evaluated Preference: NONE

Contractor Details

Address: 333 RAVENSWOOD AVE, MENLO PARK, CA, 94025

Business Categories: Category Business, Corporate Entity Tax Exempt, Foreign-Owned and U.S.-Incorporated Business, Nonprofit Organization, Not Designated a Small Business, Special Designations

Financial Breakdown

Contract Ceiling: $9,755,355

Exercised Options: $9,755,355

Current Obligation: $9,755,355

Subaward Activity

Number of Subawards: 5

Total Subaward Amount: $822,278

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED

Cost or Pricing Data: NO

Timeline

Start Date: 2023-09-30

Current End Date: 2025-12-31

Potential End Date: 2025-12-31 00:00:00

Last Modified: 2025-12-10

More Contracts from SRI International

View all SRI International federal contracts →

Other Department of Defense Contracts

View all Department of Defense contracts →

Explore Related Government Spending